Latest Focal Segmental Glomerulosclerosis (FSGS) News

Possible Tissue Injury Predictor in Transplant Recipients Found

Possible Tissue Injury Predictor in Transplant Recipients Found

Researchers may have found a predictor for focal segmental glomerulosclerosis (FSGS) in kidney transplant recipients.

FSGS May Respond to Arthritis Drug

In a small study, abatacept induced partial or complete remission of focal segmental glomerulosclerosis.

Black Race Worsens Transplant Outcomes

Black race is associated with worse renal transplant outcomes among patients with lupus nephritis and focal segmental glomerulosclerosis (FSGS), according to two studies presented at Kidney Week, the annual meeting of the American Society of Nephrology.

Black Transplant Patients with FSGS Are At Higher Risk

PHILADELPHIA—Among kidney transplant recipients with focal segmental glomerulosclerosis (FSGS), African-Americans (AA) have a greater prevalence of risk factors for allograft failure compared with other races, according to findings presented at Kidney Week 2011.

Male Gender, Older Age Raise RCC Risk in Long-Term Dialysis Patients

Development renal cell carcinoma (RCC) in patients on long-term dialysis is associated with older age, male gender, acquired renal cysts, and end-stage renal disease.

Steroids May Harm Athletes' Kidneys

Serious renal damage is a possible consequence of long-term abuse of anabolic steroids, data show .

Why African Americans Have More ESRD

Reseachers have identified, for the first time, gene variations that explain the increased burden of kidney diseases among African Americans.

Diagnosing, Treating FSGS: An Update

Focal segmental glomerulosclerosis (FSGS) is not a single disease but a histologic pattern of renal damage that initially affects the glomerulus and its tubulointerstitium.